| Net Cash Provided by (Used in) Operating Activities |
$404,880,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$448,525,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
83,633,744 |
shares |
1243% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$43,645,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$320,802,000 |
USD |
1074% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,687,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$7,189,000 |
USD |
439% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,880,000 |
USD |
383% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$31,300,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$1,969,450,000 |
USD |
1214% |
Q4 2025 |
FY 2025 |
| Current State and Local Tax Expense (Benefit) |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$7,189,000 |
USD |
439% |
Q4 2025 |
FY 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$2,716,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Interest Expense |
$30,369,000 |
USD |
|
Q4 2025 |
FY 2025 |